SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)
An SI Board Since October 1997
Posts SubjectMarks Bans Symbol
824 29 0 ALXN
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
224WL described very well what is going on. Thanks. While I did own ALXN in past cMiljenko Zuanic-8/30/2002
223If I could save Miljenko some effort, I would guess he is concerned that the morkeokalani'nui-8/29/2002
222Wilder, Thanks very much, that's exactly what I was looking for, and I, tootuck-8/29/2002
221As for RA, there is not much value attached to this program, but there is clearlkeokalani'nui-8/29/2002
220Both MI trials took longer than expected. I can not explain why, but they are lkeokalani'nui-8/29/2002
219Wilder, I have noticed that Alexion has basically languished during the recent tuck-8/29/2002
218Wilder -- with his "buy", he recommended a tight loss-stop, consistenttom r. phillips-7/31/2002
217Tom, Let us know when Don pulls out, please? :-) Wilderkeokalani'nui-7/31/2002
216Cariporide. Thanks Stuart. Message 17815928keokalani'nui-7/31/2002
215Don Worden of Worden Bros. TC2000 data and charting service called ALXN a "tom r. phillips-7/31/2002
214Pharmos tries Dexanabinol for MCI following CABG. Message 17792413keokalani'nui-7/29/2002
213Beware ye who read the previous and a general warning to all. A copy and paste keokalani'nui-7/3/2002
212J Clin Invest, July 2002, Volume 110, Number 1, 101-108 Copyright ©2002 by Miljenko Zuanic-7/1/2002
211Wilder, It's getting to be a target rich environment. I'm not table potuck-5/7/2002
210You would be tempting me - if I had any cash left ;-( nignigel bates-5/7/2002
209I've always been a little self-conscious as the only SIer for whom alxn is akeokalani'nui-5/7/2002
208Alexion and CuraGen Establish Drug Target Discovery Alliance CHESHIRE, Conn., anigel bates-3/12/2002
207...As a result of the revised collaboration with P&G, of which terms includekeokalani'nui-3/8/2002
206Parking...DC-SIGN. JOI. DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Nekeokalani'nui-3/7/2002
205>>CHESHIRE, Conn., Feb. 20 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticatuck-2/20/2002
204ALXN broke up through 200 day MA and now appears to be bouncing up off it for thtom r. phillips-1/29/2002
203Alexion Starts Phase IIb Trial of 5G1.1 in Rheumatoid Arthritis Patients CHESHInigel bates-1/29/2002
202Alexion Begins Phase III PRIMO-CABG Trial CHESHIRE, Conn. -- Alexion PharmaceutJim Oravetz-1/7/2002
201Putting the cash to work? biz.yahoo.comtom pope-12/12/2001
200I agree about the MI. Makes me nervous too. I can understand why maybe thrombokeokalani'nui-12/3/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News